Report: Trump and Allies Appear Financially Linked to Hyped Hydrochloroquine Drug

Mr. Trump first expressed interest in hydroxychloroquine a few weeks ago, telling associates that Mr. Ellison, a billionaire and a founder of Oracle, had discussed it with him.

If hydroxychloroquine becomes an accepted treatment, several pharmaceutical companies stand to profit, including shareholders and senior executives with connections to the president. Mr. Trump himself has a small personal financial interest in Sanofi, the French drugmaker that makes Plaquenil, the brand-name version of hydroxychloroquine.

The professional organization that published a positive French study cited by Mr. Trump’s allies changed its mind in recent days. The International Society of Antimicrobial Chemotherapy said, “The article does not meet the society’s expected standard.” Some hospitals in Sweden stopped providing hydroxychloroquine to treat the coronavirus after reports of adverse side effects, according to Swedish news media.

The New York Times:

Article submitted by, sheltomlee.